Publications by authors named "Aurore Hendrix"
Metastatic prostate cancer remains a challenge for clinicians. Metastases involve mainly the bone compartment and can manifest as oligometastatic disease. In this setting, the role of metastasis-directed therapies (MDT) including surgery and/or stereotactic body radiotherapy is currently evaluated.
View Article and Find Full Text PDFArticle Synopsis
- Immune checkpoint inhibitors (ICIs), like nivolumab, significantly improve outcomes for patients with advanced renal cancer, but they can cause immune-related side effects, primarily affecting organs like skin and lungs.* -
- A case study describes a patient who received eight doses of nivolumab without issues but developed brain metastases that were treated with radiotherapy, followed by a ninth dose of the drug.* -
- After the ninth dose, the patient experienced severe thrombocytopenia (low platelet count) leading to bleeding, prompting treatment with high doses of steroids and intravenous immunoglobulin, highlighting the risk of serious blood-related side effects from ICIs, especially after radiotherapy.*